Euclidean Capital as of March 31, 2021
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 13 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 46.0 | $138M | 4.2M | 32.89 | |
| Ngm Biopharmaceuticals (NGM) | 14.5 | $43M | 1.5M | 29.07 | |
| Oric Pharmaceuticals (ORIC) | 8.2 | $24M | 997k | 24.50 | |
| Alector (ALEC) | 6.6 | $20M | 981k | 20.14 | |
| Denali Therapeutics (DNLI) | 6.2 | $19M | 324k | 57.10 | |
| Foghorn Therapeutics (FHTX) | 5.6 | $17M | 1.3M | 13.18 | |
| Rapt Therapeutics (RAPT) | 5.5 | $16M | 736k | 22.20 | |
| Constellation Pharmceticls I | 4.3 | $13M | 554k | 23.39 | |
| First Financial Ban (FFBC) | 1.4 | $4.2M | 174k | 24.00 | |
| Beam Therapeutics (BEAM) | 0.8 | $2.5M | 31k | 80.05 | |
| Vir Biotechnology (VIR) | 0.4 | $1.3M | 26k | 51.27 | |
| Pinduoduo Sponsored Ads (PDD) | 0.4 | $1.1M | 8.2k | 133.84 | |
| Rubius Therapeutics | 0.1 | $339k | 13k | 26.50 |
